SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-028316
Filing Date
2016-11-08
Accepted
2016-11-08 16:06:08
Documents
48
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cnat-10q_20160930.htm 10-Q 771302
2 EX-31.1 cnat-ex311_8.htm EX-31.1 10758
3 EX-31.2 cnat-ex312_6.htm EX-31.2 11935
4 EX-32.1 cnat-ex321_7.htm EX-32.1 6603
5 EX-32.2 cnat-ex322_9.htm EX-32.2 7470
  Complete submission text file 0001564590-16-028316.txt   3178758

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cnat-20160930.xml EX-101.INS 637351
7 XBRL TAXONOMY EXTENSION SCHEMA cnat-20160930.xsd EX-101.SCH 24293
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cnat-20160930_cal.xml EX-101.CAL 30228
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cnat-20160930_def.xml EX-101.DEF 73058
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cnat-20160930_lab.xml EX-101.LAB 216843
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cnat-20160930_pre.xml EX-101.PRE 162714
Mailing Address 16745 WEST BERNARDO DRIVE Suite 200 San Diego CA 92127
Business Address 16745 WEST BERNARDO DRIVE Suite 200 San Diego CA 92127 (858) 376-2600
Conatus Pharmaceuticals Inc. (Filer) CIK: 0001383701 (see all company filings)

IRS No.: 203183915 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36003 | Film No.: 161981334
SIC: 2834 Pharmaceutical Preparations